Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma
Authors:
- J.E. KrookJKJ.E. Krook
- J.F. HiltonJHJ.F. Hilton
- G.D. MalkasianGMG.D. Malkasian
- L.K. EversonLEL.K. Everson
- J.A. JefferiesJJJ.A. Jefferies
- J.A. MailliardJMJ.A. Mailliard
- 1 September 1987
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 28 (1) , 20-24